Dihydrotestosterone-receptor complexes formed in human fibroblast cytosol prepared at 0 degrees C in the presence of sodium molybdate can be readily transformed to the DNA-binding state by heating at 25 degrees C. Under these conditions 50-70% of dihydrotestosterone-receptor complexes bind to DNA. We describe here studies of the transformation process in cytosols derived from normal cells and from fibroblasts propagated from subjects with syndromes of androgen resistance. In contrast to the situation with dihydrotestosterone, normal testosterone-receptor complexes are unstable under in vitro transforming conditions. Although equal amounts of hormone-receptor complex are formed at 0 degrees C, only 15% of testosterone-receptor complexes remain stable and acquire DNA-binding capacity after warming. This instability is not reversible upon lowering the temperature and is corrected by low concentrations (0.25 microM) of the protease inhibitor leupeptin. We have also identified two cousins with androgen resistance whose androgen-receptor complexes exhibit similar in vitro transformation lability with both dihydrotestosterone and testosterone. Phenotypic evidence in these subjects indicates that dihydrotestosterone-mediated processes are more completely impaired than are testosterone-mediated events. These findings suggest that dihydrotestosterone may amplify the androgenic signal at its targets not only by its higher affinity for the receptor but also by its more efficient conversion to the DNA-binding state and that such amplification may be less critical in target tissues in which testosterone suffices for androgenic effect. This offers one possible explanation of how a mutation that affects a single receptor protein may differentially impair the actions of two binding ligands of the receptor.
W J Kovacs, J E Griffin, D D Weaver, B R Carlson, J D Wilson
Title and authors | Publication | Year |
---|---|---|
Improvement of Late-Onset Hypogonadism Symptoms of Fermented Morinda citrifolia Extract in TM3 Leydig and TM4 Sertoli Cells
Kwon HY, Lee H, Choi JS, Lim SH, Kim T, Bae K, Jang YA, Lee JY, Choung SY, Min DS |
Nutrients | 2024 |
Inhibitory Activities of Dimeric Ellagitannins Isolated from Cornus alba on Benign Prostatic Hypertrophy
DH Park, KH Park, J Yin, MJ Kim, SE Yoon, SH Lee, JH Heo, HJ Chung, JW Kim, KM Kim, MW Lee |
Molecules (Basel, Switzerland) | 2021 |
Glucagon-like peptide-1 receptor expression and its functions are regulated by androgen
L Zhu, J Zhou, Y Pan, J Lv, Y Liu, S Yu, Y Zhang |
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie | 2019 |
The Chalice Sign: Characteristic Morphology of the Cervical Carotid Bifurcation in Patients with Loeys-Dietz Syndrome
JC Benson, W Brinjikji |
Clinical Neuroradiology | 2019 |
Steroid 5α-reductase 2 deficiency leads to reduced dominance-related and impulse-control behaviors
LJ Mosher, SC Godar, M Morissette, KM McFarlin, S Scheggi, C Gambarana, SC Fowler, TD Paolo, M Bortolato |
Psychoneuroendocrinology | 2018 |
Dihydrotestosterone: Biochemistry, Physiology, and Clinical Implications of Elevated Blood Levels
RS Swerdloff, RE Dudley, ST Page, C Wang, WA Salameh |
Endocrine reviews | 2017 |
Current status of 5α-reductase inhibitors in prostate disease management
DI Kang, JI Chung |
Korean Journal of Urology | 2013 |
Reduced Bone Mass and Muscle Strength in Male 5α-Reductase Type 1 Inactivated Mice
SH Windahl, N Andersson, AE Börjesson, C Swanson, J Svensson, S Movérare-Skrtic, K Sjögren, R Shao, MK Lagerquist, C Ohlsson, JM Vanacker |
PloS one | 2011 |
Harper's Textbook of Pediatric Dermatology
HM Goodyear |
Harper's Textbook of Pediatric Dermatology | 2011 |
Vitamins & Hormones
KJ Hare, FK Knop |
Vitamins & Hormones | 2010 |
Hormones, Brain and Behavior
J Bernal |
Hormones, Brain and Behavior | 2009 |
Molecular Basis of Steroid Action in the Prostate
YS Zhu |
Cellscience | 2005 |
5α-Reductase Isozymes in the Prostate
YS Zhu, GH Sun |
Journal of medical sciences (Taipei, Taiwan) | 2005 |
Fetal hormones and sexual differentiation
V Sobel, YS Zhu, J Imperato-McGinley |
Obstetrics and Gynecology Clinics of North America | 2004 |
Androgens in Health and Disease
CJ Bagatell, WJ Bremner |
2003 | |
Androgens and male physiology the syndrome of 5α-reductase-2 deficiency
J Imperato-McGinley, YS Zhu |
Molecular and Cellular Endocrinology | 2002 |
Discovery of Potent, Nonsteroidal, and Highly Selective Glucocorticoid Receptor Antagonists
BP Morgan, AG Swick, DM Hargrove, JA LaFlamme, MS Moynihan, RS Carroll, KA Martin, E Lee, D Decosta, J Bordner |
Journal of Medicinal Chemistry | 2002 |
Unexpected Virilization in Male Mice Lacking Steroid 5α-Reductase Enzymes
MS Mahendroo, KM Cala, DL Hess, DW Russell |
Endocrinology | 2001 |
Expression of type 1 5alpha-reductase and metabolism of testosterone in reconstructed human epidermis (SkinEthicR): a new model for screening skin-targeted androgen modulators
FX Bernard, C Barrault, A Deguercy, B Wever, M Rosdy |
International Journal of Cosmetic Science | 2000 |
Expression of type 1 5α-reductase and metabolism of testosterone in reconstructed human epidermis (SkinEthic®): a new model for screening skin-targeted androgen modulators
FX Bernard, C Barrault, A Deguercy, B Wever, M Rosdy |
International Journal of Cosmetic Science | 2000 |
Androgen-activating enzymes in the central nervous systemProceedings of Xth International Congress on Hormonal Steroids, Quebec, Canada, 17–21 June 1998
A Poletti, L Martini |
The Journal of Steroid Biochemistry and Molecular Biology | 1999 |
Neurosteroids
EE Baulieu, P Robel, M Schumacher |
1999 | |
Insulin-Like Growth Factor-I and -II in Human Benign Prostatic Hyperplasia: Relationship with Binding Proteins 2 and 3 and Androgens
S Monti, FD Silverio, S Lanzara, P Varasano, C Martini, C Tosti-Croce, F Sciarra |
Steroids | 1998 |
5α-Reductase Isozymes in the Central Nervous System
A Poletti, A Coscarella, P Negri-Cesi, A Colciago, F Celotti, L Martini |
Steroids | 1998 |
Endocrine and adrenergic pharmacological intervention in diseases of the prostate
A Rane |
British Journal of Clinical Pharmacology | 1998 |
Natural potent androgens: Lessons from human genetic models
Y Zhu, MD Katz, J Imperato-McGinley |
Baillière's Clinical Endocrinology and Metabolism | 1998 |
Evidence of Heterogeneity and Quantitative Differences of the Type 1 5α-Reductase Expression in Cultured Human Skin Cells – Evidence of its Presence in Melanocytes
W Chen, CC Zouboulis, M Fritsch, U Blume-Peytavi, V Kodelja, S Goerdt, V Luu-The, CE Orfanos |
Journal of Investigative Dermatology | 1998 |
Metabolism of steroids in the brain: a new insight into the role of 5α-reductase and aromatase in brain differentiation and functions
P Negri-Cesi, A Poletti, F Celotti |
The Journal of Steroid Biochemistry and Molecular Biology | 1996 |
9 Role of 5α-reductase in health and disease
VA Randall |
Baillière's Clinical Endocrinology and Metabolism | 1994 |
The potential for hormonal prevention trials
LG Ford, OW Brawley, JA Perlman, SG Nayfield, KA Johnson, BS Kramer |
Cancer | 1994 |
Hypogonadism
S Plymate |
Endocrinology and metabolism clinics of North America | 1994 |
The androgen resistance syndromes: Clinical and biochemical aspects
HU Schweikert |
European Journal of Pediatrics | 1993 |
Local implants of testosterone metabolites regulate vasopressin mRNA in sexually dimorphic nuclei of the rat brain
MD Brot, GJ Vries, DM Dorsa |
Peptides | 1993 |
Mutations in the ligand-binding domain of the androgen receptor gene cluster in two regions of the gene
MJ McPhaul, M Marcelli, S Zoppi, CM Wilson, JE Griffin, JD Wilson |
Journal of Clinical Investigation | 1992 |
5 Control of spermatogenesis by follicle stimulating hormone and testosterone
DM Kretser, RI McLachlan, DM Robertson, NG Wreford |
Baillière's Clinical Endocrinology and Metabolism | 1992 |
Role of 5α-Reductase Inhibitors in the Treatment of Advanced Prostatic Carcinoma
GJ Gormley |
The Urologic clinics of North America | 1991 |
Androgen resistance due to decreased amounts of androgen receptor: A reinvestigation
PB Grino, JE Griffin, JD Wilson |
Journal of Steroid Biochemistry | 1990 |
The state transitions of normal and mutant androgen-receptor complexes in human genital skin fibroblasts
M Kaufman, L Pinsky, B Gottlieb, M Trifiro |
Journal of Steroid Biochemistry | 1990 |
Determination of the affinity of a steroid for its receptor is not sufficient to measure its intrinsic hormonal activity
FJ Zeelen |
Steroids | 1990 |
Advances in Human Genetics
H Harris, K Hirschhorn |
1990 | |
Intracellular and nuclear binding of [3H]dihydrotestosterone in cultured genital skin fibroblasts of patients with severe hypospadias
HU Schweikert, M Schlüter, G Romalo |
Journal of Clinical Investigation | 1989 |
Inhibitors of steroid 5α-reductase in benign prostatic hyperplasia, male pattern baldness and acne
BW Metcalf, MA Levy, DA Holt |
Trends in Pharmacological Sciences | 1989 |
Characterization and expression of a cDNA encoding the human androgen receptor
WD Tilley, M Marcelli, JD Wilson, MJ McPhaul |
Proceedings of the National Academy of Sciences | 1989 |
A CONVENIENT “HYDROGEN TRANSFER” HYDROGENATION OF TESTOSTERONE
DM Spyriounis, G Ikonomidis, VJ Demopoulos |
Organic Preparations and Procedures International | 1989 |
Partial purification and characterisation of the human skin fibroblast androgen receptor: Detection of abnormal receptor complexes in cells from patients with androgen insensitivity syndromes
IJ McEwan, DA Rowney, MB Hodgins |
Journal of Steroid Biochemistry | 1989 |
A single-site allosteric model of intracellular androgen-receptor interaction
M Kaufman, L Pinsky |
Journal of Steroid Biochemistry | 1989 |
Androgen receptors: Structures, mutations, antibodies and cellular dynamics
S Liao, J Kokontis, T Sai, RA Hiipakka |
Journal of Steroid Biochemistry | 1989 |
High efficiency covalent radiolabeling of the human androgen receptor. Studies in cultured fibroblasts using dihydrotestosterone 17 beta-bromoacetate
WJ Kovacs, MK Turney |
Journal of Clinical Investigation | 1988 |
THE FIBROBLAST AS A MODEL FOR ANDROGEN RESISTANT STATES
IA Hughes, BA Evans |
Clinical Endocrinology | 1988 |
Steroid Receptors in Health and Disease
VK Moudgil |
1988 | |
Cloning of Human Androgen Receptor Complementary DNA and Localization to the X Chromosome
DB Lubahn, DR Joseph, PM Sullivan, HF Willard, FS French, EM Wilson |
Science | 1988 |
Syndromes of Androgen Resistance
JE Griffin, JD Wilson |
Hospital Practice | 1987 |
Hormone Resistance and Other Endocrine Paradoxes
MP Cohen, PP Foà |
1987 | |
Inherited 5α-reductase deficiency in man
J Imperato-McGinley, T Gautier |
Trends in Genetics | 1986 |
Ligand-specific thermal misbehavior of synthetic androgen-receptor complexes in genital skin fibroblasts of subjects with familial ligand-sensitive androgen resistance
M Kaufman, L Pinsky, DW Killinger |
Journal of Steroid Biochemistry | 1986 |
The Receptors
RG Rosenfeld, RL Hintz |
The Receptors | 1986 |
Steroid Hormone Resistance
GP Chrousos, DL Loriaux, MB Lipsett |
1986 | |
Steroid Hormone Resistance: Mechanisms and Clinical Aspects
GP Chrousos, DL Loriaux, MB Lipsett |
1986 | |
Mutations that impair androgen action
JD Wilson, JE Griffin |
Trends in Genetics | 1985 |
AUGMENTATION OF ANDROGEN-RECEPTOR BINDING IN VITRO: STUDIES IN NORMALS AND PATIENTS WITH ANDROGEN INSENSITIVITY
BA Evans, IA Hughes |
Clinical Endocrinology | 1985 |
Whole Cell and Nuclear Androgen Uptake in Skin Fibroblasts from Infertile Men
C Eil, GT Gamblin, JW Hodge, RV Clark, RJ Sherins |
Journal of andrology | 1985 |
Endocrine and genetic characterization of cousins with male pseudohermaphroditism: evidence that the Lubs pheno-type can result from a mutation that alters the structure of the androgen receptor
JD Wilson, BR Carlson, DD Weaver, WJ Kovacs, JE Griffin |
Clinical Genetics | 1984 |
Testosterone
DW Killinger |
Canadian Medical Association journal | 1970 |